Across TCGA pan-cancer cohorts, RNU4-69P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU4-69P data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU4-69P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU4-69P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.
KIRC, HNSC, and LUSC are the cancer types where RNU4-69P RNA most reproducibly stratifies survival.